Precarn to review options for continuation of 20-year-old commercialization program


The appointment of Dr Henri Rothschild as president and CEO of Precarn Inc sets in motion a strategic review that will determine the fate of one of Canada's most enduring commercialization programs. Currently focused on robotics and intelligent systems, its future direction and potential source of financial support will be determined over the coming weeks with greater clarity once the federal Budget is delivered on January 27.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.